Journal of Cardiovascular Pharmacology, 0160-2446

Journal

  1. 1993
  2. Crijns, HJ., Oosterhuis, B., Wiesfeld, ACP., De Bruin, H., Mensink, CK., Jonkman, JHG., ... Lie, KI. (1993). Electrophysiologic and Pharmacokinetic Profile of the New Antiarrhythmic Drug TYB-3823 in Humans. Journal of Cardiovascular Pharmacology, 21(1), 1-6. https://doi.org/10.1097/00005344-199301000-00001
  3. 1992
  4. Wilhelm, D., Wilffert, B., Janssens, W. J., Leidig, A., Meuter, C., Ebbert, M., & Peters, T. (1992). In vitro pharmacology of R 80122, a novel phosphodiesterase inhibitor. Journal of Cardiovascular Pharmacology, 20(5), 705-714.
  5. van Wijngaarden, J., Monnink, S. H. J., van Gilst, W. H., de Graeff, P. A., de Langen, C. D. J., Wesseling, H., & Bartels, H. (1992). Captopril modifies the response of infarcted rat hearts to isoprenaline stimulation. Journal of Cardiovascular Pharmacology, 19(5), 741-747.
  6. Tobé, T. J. M., de Langen, CD. J., Weersink, E. G. L., van Wijngaarden, J., Bel, K. J., de Graeff, P. A., ... Wesseling, H. (1992). The angiotensin converting enzyme inhibitor perindopril improves survival after experimental myocardial infarction in pigs. Journal of Cardiovascular Pharmacology, 19(5), 732-740.
  7. van Wijngaarden, J., Tobe, T. J. M., Weersink, E. G. L., Bel, K. J., de Graeff, P. A., de Langen, C. D. J., ... Wesseling, H. (1992). Effects of early angiotensin-converting enzyme inhibition in a pig model of myocardial ischemia and reperfusion. Journal of Cardiovascular Pharmacology, 19(3), 408-416.
  8. WILHELM, D., WILFFERT, B., JANSSENS, WJ., LEIDIG, A., MEUTER, C., EBBERT, M., & Peters, T. (1992). Invitro pharmacology of r-80122, a novel phosphodiesterase inhibitor. Journal of Cardiovascular Pharmacology, 20(5), 705-714.
  9. 1991
  10. Portegies, M. C. M., Schmitt, R., Kraaij, C. J., Braat, S. H. J. G., Gassner, A., Hagemeijer, F., ... Lie, K. I. (1991). Lack of negative inotropic effects of the new calcium antagonist Ro 40-5967 in patients with stable angina pectoris. Journal of Cardiovascular Pharmacology, 18(5), 746-751. https://doi.org/10.1097/00005344-199111000-00013
  11. Fulle, H-J., Endres, S., Sinha, B., Stoll, D., Weber, P. C., & Gerzer, R. (1991). Effects of SIN-1 on cytokine synthesis in human mononuclear cells. Journal of Cardiovascular Pharmacology, 17(SUPPL. 3), S113-S116.
  12. 1990
  13. DELANGEN, CDJ., VANDENTOREN, EW., TIO, RA., LIE, KI., & WESSELING, H. (1990). EFFECTS OF ISRADIPINE ON HEMODYNAMIC PARAMETERS AND VENTRICULAR-TACHYCARDIA IN HEALED MYOCARDIAL-INFARCTION. Journal of Cardiovascular Pharmacology, 15(2), 254-258.
  14. De Muinck, E. D., Lie, K. I., Von Mengden, H. J., Reck, R., & Verkenne, P. (1990). Bisoprolol Pilot Studies in Myocardial Infarction. Journal of Cardiovascular Pharmacology, 16, S196-S200.
  15. 1989
  16. DUNSELMAN, PHJM., EDGAR, B., SCAF, AHJ., KUNTZE, CEE., VANBRUGGEN, A., LIE, KI., & WESSELING, H. (1989). PLASMA-CONCENTRATION EFFECT RELATIONSHIP OF FELODIPINE INTRAVENOUSLY IN PATIENTS WITH CONGESTIVE HEART-FAILURE. Journal of Cardiovascular Pharmacology, 14(3), 438-443.
  17. 1988
  18. 1987
  19. 1986
  20. 1985
  21. WILFFERT, B., MATHY, MJ., DEJONGE, A., THOOLEN, MJMC., TIMMERMANS, PBMWM., & VANZWIETEN, PA. (1985). INFLUENCE OF BAY K-8644 ON PRESSOR EFFECTS OF B-HT-920 AND CIRAZOLINE IN PITHED CATS. Journal of Cardiovascular Pharmacology, 7(1), 26-29.
  22. 1984

ID: 881960